entity

IMMUNE_EVASION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about IMMUNE_EVASION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

8Connections

0Hypotheses

1Analyses

4Outgoing

4Incoming

0Experiments

2Debates

No AI portrait yet

Outgoing (4)

Target	Relation	Type	Str
PD-L1 upregulation	associated_with	phenotype	0.70
T cell exclusion	associated_with	phenotype	0.70
Tumor Progression	causes	phenotype	0.70
T_CELLS	inhibits	cell_type	0.64

Incoming (4)

Source	Relation	Type	Str
CANCER_CELLS	activates	cell_type	0.72
ALK inhibitor resistance	causes	phenotype	0.70
PD-L1 upregulation	associated_with	phenotype	0.70
C3	activates	protein	0.56

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Does Alectinib truly bind C1q directly with high affinity, or is this an experim

molecular biology | 2026-04-17 | 10 hypotheses Top: 0.445

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (2)

Multi-agent debates referencing this entity

The fundamental premise remains unvalidated despite extensive mechanistic specul

closed · Rounds: 4 · Score: 1.00 · 2026-04-19

The fundamental premise remains unvalidated despite extensive mechanistic specul

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Related Research

Hypotheses and analyses mentioning IMMUNE_EVASION in their description or question text

No additional research found